| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16714-770-01 | 16714-770 | HUMAN PRESCRIPTION DRUG | Rasagiline | Rasagiline | TABLET | ORAL | 20180417 | N/A | ANDA | ANDA201889 | NorthStar RxLLC | RASAGILINE MESYLATE | .5 mg/1 | 30 TABLET in 1 BOTTLE (16714-770-01) |
| 16714-771-01 | 16714-771 | HUMAN PRESCRIPTION DRUG | Rasagiline | Rasagiline | TABLET | ORAL | 20180417 | N/A | ANDA | ANDA201889 | NorthStar RxLLC | RASAGILINE MESYLATE | 1 mg/1 | 30 TABLET in 1 BOTTLE (16714-771-01) |
| 67877-259-30 | 67877-259 | HUMAN PRESCRIPTION DRUG | Rasagiline | Rasagiline | TABLET | ORAL | 20171030 | N/A | ANDA | ANDA201889 | Ascend Laboratories, LLC | RASAGILINE MESYLATE | .5 mg/1 | 30 TABLET in 1 BOTTLE (67877-259-30) |
| 67877-260-30 | 67877-260 | HUMAN PRESCRIPTION DRUG | Rasagiline | Rasagiline | TABLET | ORAL | 20171030 | N/A | ANDA | ANDA201889 | Ascend Laboratories, LLC | RASAGILINE MESYLATE | 1 mg/1 | 30 TABLET in 1 BOTTLE (67877-260-30) |